1 / 8

Surveillance Activities during Pandemic Phases

Surveillance Activities during Pandemic Phases. Anne-Luise Winter APHEO-COMOH Workshop Toronto February 1, 2007. Objectives of Pandemic surveillance. To detect early the entry of the Pandemic strain in Ontario To rapidly determine circulating strains in Ontario

kenneth-smith
Download Presentation

Surveillance Activities during Pandemic Phases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Surveillance Activities during Pandemic Phases Anne-Luise Winter APHEO-COMOH Workshop Toronto February 1, 2007

  2. Objectives of Pandemic surveillance • To detect early the entry of the Pandemic strain in Ontario • To rapidly determine circulating strains in Ontario • To provide data on circulating influenza strains • To monitor activity and patterns of distribution of ILI • To estimate the impact of the Pandemic • To describe affected population/s, mode/s of transmission, risk factors • To detect unusual events • To track occurrence, severity, and progression by WHO/PHAC phase

  3. Interpandemic Phases • No new influenza virus subtypes detected in humans  A circulating animal influenza virus subtype poses a substantial risk of human disease Surveillance: • Routine influenza surveillance • Communication of phase progression

  4. Pandemic alert phases • Human infection/s with a new subtype. Rare  limited  larger cluster/s of human to human spread Surveillance • Layered progression of activities • Detection of the novel strain, heightened surveillance for detection of any unusual cases/clusters (e.g. FRI/SRI surveillance) done through strain characterization of ~ 10% of all isolates plus atypical cases, their close contacts with ILI and unusual outbreaks • Continue with heightened surveillance until no longer sustainable  aggregate reporting • Ongoing review of case definition • Ongoing evaluation of epidemiology of novel strain

  5. Interpandemic (seasonal) surveillance components

  6. Pandemic • Increased and sustained transmission in general population Surveillance: • Utilization of pandemic reporting tools, various data collection systems (portal for aggregate data + secure platform for case level data) • Case-level information collected on a small proportion of cases • Assessment centres/hospitals/LTCHs for aggregate and case level data • Monitor uptake, efficacy, adverse events associated with vaccines and antivirals • Ongoing evaluation of epidemiology, to direct priorities to high-risk group/s • Diagnosis by clinical, not lab, criteria • Prioritization of laboratory testing

  7. Postpandemic Period • Recovery/Resolution Surveillance: • Estimate burden of disease • Evaluate surveillance systems • Eventual resumption of interpandemic activities, scaling down pandemic surveillance as appropriate

  8. Questions? Anne-Luise Winter: anne-luise.winter@moh.gov.on.ca (416) 327-7301

More Related